RET and medullary thyroid gland carcinoma: The current guidelines (ATA 2015, ESMO 2019) specify fine-needle aspiration (FNA) biopsy, ultrasound (US) of the neck, serum Ctn and CEA level analyses and RET gene mutation analysis as the most important for MTC detection and management.